Valley National Advisers’s Lisata Therapeutics LSTA Stock Holding History

Valley National Advisers’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2	Closed	-$1K	–	1097
2023 Q2	$1K	Hold	2	–	–	﹤0.01%	904
2023 Q1	$0	Hold	2	–	–	﹤0.01%	937
2022 Q4	$0	Hold	2	–	–	﹤0.01%	922
2022 Q3	$0	Sell	2 -1	-33%	-$7	﹤0.01%	960
2022 Q2	$0	Hold	3	–	–	﹤0.01%	939
2022 Q1	$0	Hold	3	–	–	﹤0.01%	956
2021 Q4	$0	Hold	3	–	–	﹤0.01%	944
2021 Q3	$0	Hold	3	–	–	﹤0.01%	912
2021 Q2	$0	Hold	3	–	–	﹤0.01%	918
2021 Q1	$0	Hold	3	–	–	﹤0.01%	886
2020 Q4	$0	Hold	3	–	–	﹤0.01%	839
2020 Q3	$0	Hold	3	–	–	﹤0.01%	811
2020 Q2	$0	Hold	3	–	–	﹤0.01%	821
2020 Q1	$0	Hold	3	–	–	﹤0.01%	803
2019 Q4	$0	Hold	3	–	–	﹤0.01%	794
2019 Q3	$0	Buy	+3	New	+$117	﹤0.01%	797

Other funds holding LSTA

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Valley National Advisers's LSTA Position: Q3 2023 in Review

Valley National Advisers sold out of Lisata Therapeutics (LSTA) in Q3 2023, closing a stake of 2 shares — an estimated $1K sold.

Valley National Advisers first reported a position in LSTA in Q3 2019 and held it in 16 quarters. The position peaked at $1K in Q2 2023. 21 funds tracked by Wall St. Rank hold LSTA as of Q3 2023.

Valley National Advisers reported no remaining Lisata Therapeutics position as of Q3 2023 after selling out during the quarter.
Valley National Advisers sold 2 Lisata Therapeutics shares in Q3 2023, an estimated $1K.
Valley National Advisers first reported a position in Lisata Therapeutics in Q3 2019 and held it in 16 quarters.
Valley National Advisers's Lisata Therapeutics position peaked at $1K in Q2 2023.
21 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2023.

Based on Valley National Advisers's 13F filing for Q3 2023, filed 13 Nov 2023.